Visual8 signs on to develop custom capacity planning system for Octapharma.
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell-lines. Octapharma employs approximately 6,000 people worldwide to support the treatment of patients in over 100 countries with products across the following therapeutic areas: Haematology (coagulation disorders), Immunotherapy (immune disorders) and Critical Care.
Octapharma owns six state-of-the-art production facilities which are highly regulated to manufacture and distribute high-quality human protein products in Austria, France, Germany, Sweden and Mexico. As such the company faces a unique and challenging planning environment. Planners must concurrently balance market demands, regulatory constraints and plant capabilities.
In this context, Octapharma contracted Visual8 to design and develop an integrated production planning solution, which provides decision support to the corporate planning team in its allocation of production in order to fulfil demand while balancing resources.
Commissioning was completed as of August 1, 2015 and the system is now in use by the corporate planning group. Visual8 has transitioned to a supportive role and is excited to work with Octapharma on expanding the existing system and other future planning and scheduling endeavours.